Results 261 to 270 of about 5,909,358 (337)

Correction to 'Inter-species differences in wound-healing rate: a comparative study involving primates and rodents' (2025), by Matsumoto-Oda <i>et al</i>. [PDF]

Proc Biol Sci
Matsumoto-Oda A, Utsumi D, Takahashi K, Hirata S, Nyachieo A, Chai D, Jillani N, Raymond M.   +7 more
europepmc   +1 more source

Effects of Non‐Aspirin Nonsteroidal Anti‐Inflammatory Drugs on Acute Intracerebral Hemorrhage

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite celecoxib, a cyclooxygenase‐2 inhibitor, promoting functional recovery from intracerebral hemorrhage (ICH) by reducing inflammation‐mediated perihematomal edema in rat models, the evidence of its effects on patient outcomes remains limited.
Shin‐Joe Yeh, Sung‐Chun Tang, Li‐Kai Tsai, Jiann‐Shing Jeng   +3 more
wiley   +1 more source

Correction for Hoffmann et al., Cancer cells suppress NK cell activity by actin-driven polarization of inhibitory ligands to the immunological synapse. [PDF]

Proc Natl Acad Sci U S A
europepmc   +1 more source

ICU‐EEG Pattern Detection by a Convolutional Neural Network

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Patients in the intensive care unit (ICU) often require continuous EEG (cEEG) monitoring due to the high risk of seizures and rhythmic and periodic patterns (RPPs). However, interpreting cEEG in real time is resource‐intensive and heavily relies on specialized expertise, which is not always available.
Giulio Degano, Hervé Quintard, Andreas Kleinschmidt, Nikita Francini, Oana E. Sarbu, Pia De Stefano   +5 more
wiley   +1 more source

Student protests in Serbia: change the country or change countries. [PDF]

Lancet Reg Health Eur
Vučković B, Krčo M.
europepmc   +1 more source

SYHA1813, A VEGFR and CSF1R Inhibitor, in Patients With Recurrent High‐Grade Gliomas: A Multicenter, Open‐Label Phase I Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Recurrent high‐grade gliomas have a poor prognosis and limited therapeutic options. This study aimed to evaluate the safety and efficacy of SYHA1813, a dual inhibitor of VEGFR and CSF1R, in patients with recurrent high‐grade gliomas.
Zhuang Kang, Shenglan Li, Liang Wang, Qianxue Chen, Weiguo Hu, Ting Lei, Ying Mao, Jing Zhang, Xiaojun Xiang, Qiming Wang, Zhengwen He, Tao Sun, Yulei Wang, Mengqian Huang, Rong Zhang, Feng Chen, Wenbin Li   +16 more
wiley   +1 more source

Correction for Tobias et al., Biodiversity conservation requires integration of species-centric and process-based strategies. [PDF]

Proc Natl Acad Sci U S A
europepmc   +1 more source

The admissibility of digital evidence from open-source forensic tools: Development of a framework for legal acceptance. [PDF]

PLoS One
Ismail I, Akram Zainol Ariffin K.
europepmc   +1 more source

Correction for Mitani et al., Microscopic and structural observations of actin filament capping and severing by cytochalasin D. [PDF]

Proc Natl Acad Sci U S A
europepmc   +1 more source